Fulvestrant/Faslodex Hormon w proszku

99% Faslodex Anti Estrogen Hormone Fulvestrant CAS129453-61-8

Fulwestrant/Faslodex Details:

Fulwestrant nazwa: Fulwestrant

Fulwestrant CAS:129453-61-8
Fulvestrant Synonyms: Faslodex
Fulvestrant Molecular Fomular:C32H47F5O3S
Fulvestrant Molecular Weight:606.77
Fulvestrant Density:1.201 g/cm3
Fulvestrant Melting Point:104-106° C
Fulvestrant Boiling Point:674.8 ° C w 760 mmHg

Fulwestrant/Faslodex Opis:

Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.

Fulvestrant Acetate is indicated for the treatment of hormone receptor positive metastatic breast cancer inpostmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.

Fulvestrant also called Faslodex or AstraZeneca,is is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It works by blocking the actions of estrogen in the body. Fulvestrant is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.Certain types of breast cancer use estrogen to grow and multiply in the body.

Fulwestrant/Faslodex Aplikacji:

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone.

These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the

effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops

oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of

receptors the cancer cell has.

Fulwestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast

cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an

estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen

receptor.

Fulwestrant/Faslodex and Bodybuilding PCT:

Fulvestrant is used to treat some hormone-related breast cancer and postmenopausal women whose breast cancer has progressed after treatment with other anti-estrogen medication.It is an estrogen receptor antagonist and works by blocking estrogen from tumors that need estrogen to grow.Fulvestrant is also being studied in the treatment of other types of cancer,it is used to treat hormone receptor positive breast cancer in women who have experienced menopause and whose breast cancer has worsened after they were treated with antiestrogen medications such as tamoxifen.This can slow or stop the growth of some breast tumors that need estrogen to grow.